6 months ago
PFE
AnalystsColin BristowColin Bristow's Stock Forecasts
AnalystsColin Bristow
Sectors:
Industries:
Analyst Ranking
Bottom 15%
#3916 out of 4554 analysts
Average Return
-2.66%
Win Rate
38%15 out of 40
Risk vs Reward
Poor
Good
Colin Bristow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alx Oncology Holdings IncALXO | +146.71% | $6.38 | $15.74 | 2023-10-03 - 2024-04-18 | Strong Buy |
Molecular Templates IncMTEM | +136.78% | $107.25 | $253.95 | 2019-04-28 - 2020-04-29 | Strong Buy |
Alx Oncology Holdings IncALXO | +114.84% | $5.19 | $11.15 | 2023-03-14 - 2024-03-14 | Strong Buy |
Bioxcel Therapeutics IncBTAI | +76.69% | $18.49 | $32.67 | 2022-02-15 - 2023-02-15 | Strong Buy |
Eli Lilly & CoLLY | +59.35% | $360.01 | $573.67 | 2022-12-14 - 2023-12-14 | Strong Buy |
Colin Bristow Analyst Color
Get additional color on Colin Bristow's coverage of popular stocks
a year ago
PFE
2 years ago
MRK
2 years ago
ABBV
2 years ago
MRK
2 years ago
PFE
Colin Bristow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $1,099.00 | +22.93% | Maintains | 3 days ago |
Amgen IncAMGN | 4 | Hold | $284.00 | +8.09% | Maintains | 3 days ago |
Biogen IncBIIB | 9 | Hold | $214.00 | +12.32% | Maintains | 3 days ago |
Gilead Sciences IncGILD | 2 | Hold | $75.00 | +13.36% | Maintains | 3 days ago |
Vertex Pharmaceuticals IncVRTX | 11 | Strong Buy | $466.00 | +18.43% | Maintains | 3 days ago |
Engene Holdings IncENGN | 1 | Strong Buy | $37.00 | +161.12% | Initiates Coverage On | 23 days ago |
Rocket Pharmaceuticals IncRCKT | 2 | Strong Buy | $54.00 | +129.98% | Maintains | 2 months ago |
Sarepta Therapeutics IncSRPT | 4 | Strong Buy | $167.00 | +43.29% | Maintains | 2 months ago |
Bioxcel Therapeutics IncBTAI | 3 | Hold | $4.00 | +56.86% | Downgrades | 2 months ago |
Merck & Co IncMRK | 3 | Strong Buy | $148.00 | +18.18% | Maintains | 3 months ago |
Pfizer IncPFE | 4 | Hold | $27.00 | +6.34% | Maintains | 4 months ago |
Immunovant IncIMVT | 4 | Strong Buy | $56.00 | +97.74% | Maintains | 5 months ago |
Alx Oncology Holdings IncALXO | 3 | Strong Buy | $27.00 | +71.54% | Maintains | 7 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $420.00 | N/A | Maintains | a year ago |
Omeros CorpOMER | 2 | Hold | $2.00 | N/A | Downgrades | a year ago |
Prokidney CorpPROK | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Abbvie IncABBV | 2 | Hold | $146.00 | N/A | Maintains | 2 years ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $75.00 | N/A | Maintains | 2 years ago |
C4 Therapeutics IncCCCC | 1 | Strong Buy | $26.00 | N/A | Maintains | 2 years ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 3 years ago |
Molecular Templates IncMTEM | 2 | Hold | $195.00 | N/A | Initiates Coverage On | 3 years ago |
Ptc Therapeutics IncPTCT | 1 | Hold | $55.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.